Article ; Online: In severe COVID-19, adding lopinavir-ritonavir to usual care did not improve mortality at 28 days.
2021 Volume 174, Issue 1, Page(s) JC3
Abstract: Source citation: RECOVERY Collaborative Group. ...
Abstract | Source citation: RECOVERY Collaborative Group. |
---|---|
MeSH term(s) | Administration, Oral ; Aged ; Antiviral Agents/administration & dosage ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; COVID-19/mortality ; Drug Combinations ; Female ; Hospitalization ; Humans ; Lopinavir/administration & dosage ; Lopinavir/therapeutic use ; Male ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Ritonavir/administration & dosage ; Ritonavir/therapeutic use ; SARS-CoV-2 ; United Kingdom |
Chemical Substances | Antiviral Agents ; Drug Combinations ; Lopinavir (2494G1JF75) ; Ritonavir (O3J8G9O825) |
Language | English |
Publishing date | 2021-01-05 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 336-0 |
ISSN | 1539-3704 ; 0003-4819 |
ISSN (online) | 1539-3704 |
ISSN | 0003-4819 |
DOI | 10.7326/ACPJ202101190-003 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ua VI Zs.178/2: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.